Market by Product Type, Industry Verticals, and Country | Forecast 2021-2028
North America’s sleep apnea therapeutics and diagnostics market is expected to witness revenue growth in the forecast years 2021-2028, growing with a CAGR of 6.22%.
The countries examined in this
market include:
• The United States
• Canada
The number of people suffering
from chronic conditions like obesity, stroke, atrial defibrillation, etc., in
the US, is on the rise. This has led to an increase in the prevalence of sleep
apnea. This growing prevalence of the condition, along with the favorable
reimbursement landscape in the country, essentially propels the market growth
here.
The United States is known for
its advanced healthcare systems. The treatment for sleep apnea is highly
diversified, and includes PAP devices, oral appliances, adaptive servo
ventilators, neurostimulators, and wearables. In addition, the diagnosis
segment has integrated several digital solutions, such as novel wearables and
mobile applications, for sleep screening & monitoring, and
teleconsultations.
However, the main concern here
is the lack of adherence to medication by patients and the unequal treatment
landscape. The non-adherence to treatment is often due to hospital
readmissions, particularly for cardiovascular patients who suffer from sleep
apnea.
Further, the COVID-19 pandemic
has had a mixed impact on the US market. For instance, clinical polysomnography
(PSG) testing for sleep apnea was suspended for an unspecified period, from
March 2020. This, however, propelled the surge in teleconsultations for sleep
apnea diagnosis and treatment. This fueled the growth of home sleep testing
devices, remote sleep screening diagnostics, and monitoring devices & solutions.
Cadwell Industries Inc is one
of the globally leading companies for neurophysiology equipment. It also offers
products for sleep disorders, for example, the Easy III PSG, which is a sleep
diagnostic system. Other than this, it also offers Silent Sleep, an oral
appliance to treat snoring and obstructive sleep apnea, as well as electrodes
and instrument accessories. Founded in 1979, the US-based company is
headquartered in Kennewick, Washington.
1. NORTH
AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2.2. KEY
INSIGHTS
2.3. PORTER'S
FIVE FORCES MODEL
2.3.1. BARGAINING
POWER OF BUYERS
2.3.2. BARGAINING
POWER OF SUPPLIERS
2.3.3. THREAT
OF SUBSTITUTE PRODUCTS
2.3.4. THREAT
OF NEW ENTRANTS
2.3.5. COMPETITIVE
RIVALRY
2.4. LEGAL,
POLICY & REGULATORY FRAMEWORK
2.5. SUPPLY
CHAIN OUTLOOK
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. ACQUISITIONS
& MERGERS
2.8.2. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.8.3. CONTRACTS
AND PARTNERSHIPS
2.8.4. BUSINESS
EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
2.9. MARKET
DRIVERS
2.9.1. AWARENESS
RELATED TO THE NEGATIVE IMPACT OF UNTREATED SLEEP APNEA
2.9.2. RISE
IN GERIATRIC POPULATION AND OBESITY CASES
2.9.3. DISTURBED
SLEEP DUE TO INCREASED USE OF GADGETS AT NIGHT-TIME
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST OF SLEEP APNEA DEVICES
2.10.2. UNFAVORABLE
REIMBURSEMENT LANDSCAPE
2.10.3. LACK
OF PATIENT ADHERENCE TO THE TREATMENT RECOMMENDED
2.11. MARKET
OPPORTUNITIES
2.11.1. INCREASING
USAGE OF AT-HOME MONITORING DEVICES
2.11.2. ADVANCEMENTS
IN TECHNOLOGY
3. NORTH
AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – BY PRODUCT TYPE
3.1. THERAPEUTICS
3.1.1. POSITIVE
AIRWAY PRESSURE (PAP) DEVICES
3.1.2. OXYGEN
DEVICES
3.1.3. MASKS
AND ACCESSORIES
3.1.4. ORAL
APPLIANCES
3.1.5. ADAPTIVE
SERVO VENTILATION (ASV) DEVICES
3.2. DIAGNOSTICS
AND MONITORING
3.2.1. POLYSOMNOGRAPHY
DEVICE (PSG)
3.2.2. OXIMETER
3.2.3. ACTIGRAPHY
MONITORING DEVICE
3.2.4. RESPIRATORY
POLYGRAPH
3.2.5. SLEEP
APNEA SCREENING DEVICE
3.2.6. OTHER
DIAGNOSTICS AND MONITORING DEVICES
4. NORTH
AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET – BY INDUSTRY VERTICALS
4.1. HOSPITALS
& SLEEP LABORATORIES
4.2. HOME
CARE SETTINGS
5. GEOGRAPHICAL
ANALYSIS – NORTH AMERICA
5.1. COUNTRY
ANALYSIS
5.1.1. THE
UNITED STATES
5.1.2. CANADA
6. COMPETITIVE
LANDSCAPE
6.1. BMC
MEDICAL CO LTD
6.2. BRAEBON
MEDICAL CORPORATION
6.3. CADWELL
INDUSTRIES INC
6.4. DEVILBISS
HEALTHCARE LLC
6.5. FISHER
& PAYKEL HEALTHCARE CORPORATION LIMITED
6.6. GE
HEALTHCARE (GENERAL ELECTRIC COMPANY)
6.7. INVACARE
CORPORATION
6.8. ITAMAR
MEDICAL LTD
6.9. KONINKLIJKE
PHILIPS NV
6.10. MEDTRONIC
PLC
6.11. NIHON
KOHDEN CORPORATION
6.12. SIGNIFIER
MEDICAL TECHNOLOGIES LIMITED
6.13. RESMED
INC
6.14. SMITHS
MEDICAL INC
6.15. SOMNOMEDICS
GMBH
6.16. TELEFLEX
INCORPORATED
6.17. VYAIRE
MEDICAL INC
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.1.1. OBJECTIVES
OF STUDY
7.1.2. SCOPE
OF STUDY
7.2. SOURCES
OF DATA
7.2.1. PRIMARY
DATA SOURCES
7.2.2. SECONDARY
DATA SOURCES
7.3. RESEARCH
METHODOLOGY
7.3.1. EVALUATION
OF PROPOSED MARKET
7.3.2. IDENTIFICATION
OF DATA SOURCES
7.3.3. ASSESSMENT
OF MARKET DETERMINANTS
7.3.4. DATA
COLLECTION
7.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN
$ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: ACQUISITIONS
& MERGERS
TABLE 4: NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 5: CONTRACTS AND
PARTNERSHIPS
TABLE 6: BUSINESS
EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
TABLE 7: NORTH AMERICA
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2028 (IN
$ MILLION)
TABLE 8: NORTH AMERICA
THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA
DIAGNOSTICS AND MONITORING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY INDUSTRY VERTICALS, 2021-2028
(IN $ MILLION)
TABLE 11: NORTH AMERICA
SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $
MILLION)
FIGURE 1: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 2: PORTER'S FIVE FORCES MODEL
FIGURE 3: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET,
BY PRODUCT TYPE, 2020 & 2028 (IN %)
FIGURE 4: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET,
BY THERAPEUTICS, 2021-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA SLEEP APNEA THERAPEUTICS MARKET, BY POSITIVE
AIRWAY PRESSURE (PAP) DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA SLEEP APNEA THERAPEUTICS MARKET, BY OXYGEN
DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA SLEEP APNEA THERAPEUTICS MARKET, BY MASKS AND
ACCESSORIES, 2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA SLEEP APNEA THERAPEUTICS MARKET, BY ORAL
APPLIANCES, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA SLEEP APNEA THERAPEUTICS MARKET, BY ADAPTIVE
SERVO VENTILATION (ASV) DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET,
BY DIAGNOSTICS AND MONITORING, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY
POLYSOMNOGRAPHY DEVICE (PSG), 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY OXIMETER,
2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY ACTIGRAPHY
MONITORING DEVICE, 2021-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY
RESPIRATORY POLYGRAPH, 2021-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY SLEEP
APNEA SCREENING DEVICE, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA DIAGNOSTICS AND MONITORING MARKET, BY OTHER
DIAGNOSTICS AND MONITORING DEVICES, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET,
BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET,
BY HOSPITALS & SLEEP LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET,
BY HOME CARE SETTINGS, 2021-2028 (IN $ MILLION)
FIGURE 20: THE UNITED STATES SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
2021-2028 (IN $ MILLION)
FIGURE 21: CANADA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET 2021-2028
(IN $ MILLION)